BeyondSpring Inc.

09/19/2024 | Press release | Archived content

Lancet Respiratory Medicine 2024

Plinabulin plus docetaxel versus docetaxel in patients with non-small-cell lung cancer after disease progression on platinum-based regimen (DUBLIN-3): a phase 3, international, multicentre, single-blind, parallel group, randomised controlled trial

The Lancet Respiratory Medicine

Share

BeyondSpring Inc. published this content on September 19, 2024, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on January 12, 2026 at 08:28 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]